FDA Approves Higher-Dose Wegovy, Intensifying Novo Nordisk’s Battle for Dominance in the Exploding Obesity Drug Market
In a pivotal move set to dramatically reshape the intensely competitive landscape of obesity therapeutics, the U.S. Food and Drug Administration (FDA) on Thursday granted approval for a higher-dose version…
